Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria, Australia.
Departments of Endocrinology and Diabetes, Monash Health, Clayton, Victoria, Australia.
Hum Reprod. 2022 May 30;37(6):1255-1273. doi: 10.1093/humrep/deac077.
What is the natural history of reproductive, psychological and oncological features in women with polycystic ovary syndrome (PCOS) in comparison to those without PCOS across the life course?
Existing longitudinal data on changes in reproductive, psychological and oncological features in PCOS are inadequate and conflicting, but the limited evidence suggests that total testosterone (T) and dehydroepiandrosterone sulphate (DHEAS) levels decline more significantly in women with PCOS than in those without PCOS, and the risk of gestational diabetes is higher in pregnant women with PCOS compared to their counterparts without PCOS.
The progression of reproductive, psychological and oncological features in PCOS remains unclear, which limits prevention and early diagnosis strategies across the lifespan. Understanding the natural history of PCOS is one of the overarching priorities in PCOS research.
STUDY DESIGN, SIZE, DURATION: This is a systematic review of longitudinal cohort studies with a narrative presentation of findings. Databases MEDLINE, EMBASE, Ovid PsycInfo, CINAHL PLUS and EBM reviews were searched between 15 January 2020 and 11 February 2021 with no language restrictions. Only studies published from the year 1990 to February 2021 were included.
PARTICIPANTS/MATERIALS, SETTING, METHODS: In line with current guidelines for the assessment and management of PCOS, we included studies where participants were females with PCOS diagnosed according to the 2003 Rotterdam or the 1990 National Institutes of Health (NIH) consensus criteria.
A total of 21 longitudinal studies including 62 123 participants over four continents reported reproductive, psychological and/or oncological outcomes. Participants were females aged between 15 and 49 years at baseline, with follow-up periods ranging from 4 weeks to 32 years. Consistent evidence based on limited studies suggests that total T and DHEAS levels decline to a greater degree in women with PCOS compared to those without PCOS, and the risk gestational diabetes is higher in women with PCOS than in those without PCOS. Evidence reporting changes over time in the majority of the remaining outcomes was unclear due to conflicting and/or insufficient information.
LIMITATIONS, REASONS FOR CAUTION: There was extreme heterogeneity between studies in terms of study setting, population characteristics, follow-up period, effect measures used and laboratory testing approaches.
Understanding the natural history of PCOS and changes in diagnostic, reproductive, psychological and oncological features of PCOS across the lifespan is still a challenge and the existing literature is both limited and conflicting. It is important that future long-term prospective longitudinal studies are conducted in unselected and well-characterized populations.
STUDY FUNDING/COMPETING INTEREST(S): This specific study was not funded. S.K. is supported by scholarships from the Research Training Program of the Commonwealth of Australia and Monash University; H.J.T. is supported by an Australian National Health and Medical Research Council fellowship; and A.E.J. is supported by the Australian National Health and Medical Research Council's Centre for Research Excellence in Women's Health in Reproductive Life. R.A. was employed by the American Society for Reproductive Medicine and is a consultant to Spruce Biosciences and Fortress Biotech. The other authors have no conflicts of interest to declare.
Prospero registration number: CRD42020165546.
与多囊卵巢综合征(PCOS)女性相比,无 PCOS 女性在整个生命周期中的生殖、心理和肿瘤特征的自然史如何?
现有关于 PCOS 患者生殖、心理和肿瘤特征变化的纵向数据不足且存在冲突,但有限的证据表明,PCOS 女性的总睾酮(T)和脱氢表雄酮硫酸盐(DHEAS)水平下降幅度明显大于无 PCOS 女性,且与无 PCOS 女性相比,PCOS 孕妇的妊娠糖尿病风险更高。
PCOS 的生殖、心理和肿瘤特征的进展仍不清楚,这限制了整个生命周期的预防和早期诊断策略。了解 PCOS 的自然史是 PCOS 研究的首要任务之一。
研究设计、规模、持续时间:这是一项对纵向队列研究的系统评价,并对研究结果进行了叙述性介绍。于 2020 年 1 月 15 日至 2021 年 2 月 11 日期间在 MEDLINE、EMBASE、Ovid PsycInfo、CINAHL PLUS 和 EBM 综述数据库中进行了检索,无语言限制。仅纳入 1990 年至 2021 年 2 月发表的研究。
参与者/材料、设置、方法:根据当前评估和管理 PCOS 的指南,我们纳入了根据 2003 年鹿特丹或 1990 年美国国立卫生研究院(NIH)共识标准诊断为 PCOS 的女性参与者的研究。
共有 21 项纵向研究纳入了来自四大洲的 62123 名参与者,报告了生殖、心理和/或肿瘤学结果。参与者为基线时年龄在 15 至 49 岁的女性,随访期从 4 周至 32 年不等。基于有限的研究,一致的证据表明,PCOS 女性的总 T 和 DHEAS 水平下降幅度明显大于无 PCOS 女性,且与无 PCOS 女性相比,PCOS 孕妇的妊娠糖尿病风险更高。由于信息相互矛盾和/或信息不足,大多数其余结果随时间变化的证据尚不清楚。
局限性、谨慎的原因:研究在研究环境、人群特征、随访期、使用的效应量和实验室检测方法等方面存在极大的异质性。
了解 PCOS 的自然史以及 PCOS 患者在整个生命周期中的诊断、生殖、心理和肿瘤特征的变化仍然是一个挑战,现有文献既有限又相互矛盾。重要的是,未来应在未选择和特征明确的人群中进行长期前瞻性纵向研究。
研究资助/利益冲突:这项特定研究没有得到资助。S.K. 得到了英联邦澳大利亚研究培训计划和莫纳什大学奖学金的支持;H.J.T. 得到了澳大利亚国家卫生和医学研究委员会研究员的支持;A.E.J. 得到了澳大利亚国家卫生和医学研究委员会妇女健康生殖生活卓越研究中心的支持。R.A. 曾受美国生殖医学学会雇佣,现为 Spruce Biosciences 和 Fortress Biotech 的顾问。其他作者没有利益冲突需要申报。
前瞻性注册编号:CRD42020165546。